Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News

US-China trade truce may not last as differences remain

India Infoline News Service May-21-2018

Mnuchins cease-fire declaration will soothe the nerves of investors worried that the worlds two biggest economies were on the verge of an all-out trade conflict.

Block deals on Monday, May 21

India Infoline News Service May-21-2018

Here are the block/bulk deals that took place on the NSE and the BSE on Monday, May 21, 2018.

Moody's downgrades PNB rating to Ba1 from Baa3; outlook stable

India Infoline News Service May-21-2018

The downgrade of the bank's BCA and ratings reflects the negative impact of the discovery of a number of fraudulent transactions on the bank's standalone profile, particularly its capital position.

Dr. Reddys Laboratories Q4FY18 Result Expectation

India Infoline News Service May-21-2018

Dr. Reddy's Laboratories is expected to report revenue of Rs3,664cr and PAT of Rs374cr in Q4FY18.

Will lead prices hit new high?

India Infoline News Service May-21-2018

Lead prices rallied by almost 1.50% in Mondays session.

Cipla Q4FY18 Result Expectation

India Infoline News Service May-21-2018

Cipla's revenue is expected at Rs3,914cr, up 7.3% yoy and PAT is expected at Rs410cr vs. loss of Rs60.9cr in Q4FY17.

 
Indian Equities News